Proximagen is a drug discovery and development company focused on developing small molecule therapeutics addressing diseases of the CNS, pain and inflammation. It is a wholly-owned subsidiary of Upsher-Smith Laboratories Inc. (USL), with an integrated drug discovery facility in Cambridge, UK.

Read the rest of entry »